B. Metzler seel. Sohn & Co’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
46,347
+16,293
+54% +$1.13M 0.03% 302
2025
Q4
$1.99M Buy
30,054
+20,841
+226% +$1.35M 0.02% 406
2025
Q3
$620K Sell
9,213
-2,388
-21% -$189K 0.01% 625
2025
Q2
$1.01M Sell
11,601
-6,588
-36% -$516K 0.01% 540
2025
Q1
$1.24M Buy
18,189
+4,141
+29% +$338K 0.01% 472
2024
Q4
$1.09M Sell
14,048
-8,530
-38% -$632K 0.01% 516
2024
Q3
$1.51M Sell
22,578
-34,180
-60% -$2.81M 0.02% 453
2024
Q2
$6.43M Buy
56,758
+16,886
+42% +$2.13M 0.06% 142
2024
Q1
$5.53M Buy
39,872
+18,549
+87% +$2.33M 0.06% 170
2023
Q4
$2.65M Sell
21,323
-89,584
-81% -$9.15M 0.03% 305
2023
Q3
$10.3M Sell
110,907
-32,332
-23% -$3.64M 0.16% 83
2023
Q2
$18.4M Buy
143,239
+13,172
+10% +$1.59M 0.25% 58
2023
Q1
$15.1M Buy
130,067
+6,755
+5% +$756K 0.24% 67
2022
Q4
$14M Buy
123,312
+501
+0.4% +$55K 0.24% 72
2022
Q3
$9.89M Sell
122,811
-7,337
-6% -$621K 0.18% 90
2022
Q2
$9.7M Buy
130,148
+4,184
+3% +$382K 0.16% 98
2022
Q1
$16.1M Sell
125,964
-23,584
-16% -$2.58M 0.22% 78
2021
Q4
$20.2M Buy
149,548
+21,444
+17% +$3.08M 0.26% 68
2021
Q3
$17.5M Sell
128,104
-11,044
-8% -$1.39M 0.25% 67
2021
Q2
$14.9M Buy
139,148
+5,852
+4% +$562K 0.22% 74
2021
Q1
$12M Buy
133,296
+121,576
+1,037% +$11.4M 0.2% 80
2020
Q4
$1.07M Buy
+11,720
New +$1.05M 0.02% 385

Other funds holding DXCM

B. Metzler seel. Sohn & Co's DXCM Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co increased its DexCom (DXCM) stake by 54% in Q1 2026, buying an estimated $1.13M and bringing the position to 46,347 shares worth $2.91M. The position accounts for 0.03% of the portfolio, ranked #302.

B. Metzler seel. Sohn & Co first reported a position in DXCM in Q4 2020 and has held it in 22 quarters since. The position peaked at $20.2M in Q4 2021. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 46,347 shares of DexCom worth $2.91M as of Q1 2026.
  • B. Metzler seel. Sohn & Co bought 16,293 DexCom shares in Q1 2026, an estimated $1.13M.
  • DexCom made up 0.03% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #302 holding.
  • B. Metzler seel. Sohn & Co first reported a position in DexCom in Q4 2020 and has held it in 22 quarters since.
  • B. Metzler seel. Sohn & Co's DexCom position peaked at $20.2M in Q4 2021.
  • 959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.